Cargando…
Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies
As the development and clinical application of cancer immunotherapies continue to expand, so does the need for novel methods to dissect their mechanisms of action. Antibodies are important effector molecules in cancer therapies due to their potential to bind directly to surface-expressed antigens an...
Autores principales: | van Vloten, Jacob P., Klafuric, Elaine M., Karimi, Khalil, McFadden, Grant, Petrik, James J., Wootton, Sarah K., Bridle, Byram W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677899/ https://www.ncbi.nlm.nih.gov/pubmed/31388514 http://dx.doi.org/10.1016/j.omtm.2019.06.010 |
Ejemplares similares
-
Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019) -
Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies
por: Minott, Jessica A., et al.
Publicado: (2022) -
Myeloid Cells during Viral Infections and Inflammation
por: Stegelmeier, Ashley A., et al.
Publicado: (2019) -
Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
por: van Vloten, Jacob P, et al.
Publicado: (2022) -
Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy
por: van Vloten, Jacob P., et al.
Publicado: (2021)